First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama

November 21, 2008

Panama City, Panama - The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fernández de Torrijos, the First Lady of Panama.

Joining M. D. Anderson in the initiative are the U.S. Department of State and Susan G. Komen for the Cure® who are working closely with the First Lady of Panama to finalize the partnership, which currently brings together leading medical experts and breast cancer awareness advocates in the United States, Mexico, Brazil and Costa Rica.

Breast cancer is the second leading cause of cancer-related deaths among women in Panama. According to the Panamanian Ministry of Health, more than 25 percent of Panama's population of 3.3 million is comprised of women over 40 years old and is at a greater risk of developing the disease since risk increases with age.

First announced by Mrs. Laura Bush in July 2007, the Partnership for Breast Cancer Awareness and Research of the Americas is designed to increase early breast cancer detection and reduce related deaths in the region through improved awareness, clinical resources and world-class research. The Partnership is facilitated by the U.S. Department of State and is initiated and implemented locally by participating countries. M. D. Anderson serves as the Partnership's lead medical adviser.

In Panama, the Partnership will offer the opportunity to advance new and existing initiatives focused on reducing the burden of breast cancer. Collaborative efforts in the areas of research, capacity-building and women's empowerment will be promoted.

Representatives from M. D. Anderson, Susan G. Komen For the Cure® and the U.S. State Department joined Mrs. Laura Bush and Mrs. Vivian Fernández de Torrijos to announce the initiative at an event held at the Ministry of Foreign Affairs in Panama City.

"Breast cancer continues to have a tremendous impact on women in Panama, despite good efforts to raise awareness of early detection and prevention," said Ana Maria Gonzalez-Angulo, M.D., assistant professor in M. D. Anderson's Department of Breast Medical Oncology, who represented M. D. Anderson at the announcement in Panama City. "By working collectively to advance awareness, research, training and community outreach, we can change attitudes and behaviors about breast cancer which will in turn save lives."

A team of 33 M. D. Anderson scientists and physicians serve on an advisory board for the Partnership for Breast Cancer Awareness and Research of the Americas and oversee the contribution of medical and public education resources to the initiative. M. D. Anderson has committed to making available its extensive library of educational materials on a broad spectrum of topics related to breast cancer, much of which is available in Spanish. In addition, M. D. Anderson will explore opportunities to develop specific satellite educational programs on breast cancer topics for the medical community and offer its faculty and staff as a resource to medical personnel in Panama.

John Mendelsohn, M.D., president of M. D. Anderson said, "We are pleased to have the opportunity to extend our work with the Partnership to Panama. Mrs. Fernández de Torrijos is commended for her dedication and commitment to reducing breast cancer and her efforts to engage the Partnership for the benefit of women in Panama, across Latin America and around the world."

To date, M. D. Anderson has established academic and educational relationships with 25 premier cancer centers around the world, and partnered with the Department of State on a similar breast cancer initiative in the Middle East formed in 2006.
-end-
About M. D. Anderson

The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 39 Comprehensive Cancer Centers designated by the National Cancer Institute. For five of the past eight years, M. D. Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News and World Report.

University of Texas M. D. Anderson Cancer Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.